Abstract:SESSION TITLE: Lung Cancer: Imaging SESSION TYPE: Original Investigation Poster PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM PURPOSE: The aim of this study was to analyze the prognostic impact of preoperative fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) on pathological nodal involvement and long-term survival in patients with completely resected clinical (c-) N0 non-small cell lung cancer (NSCLC). METHODS: We retrospectively reviewed 255 patients with cN0 NSCLC who underwent 18F-FDG PET/CT scan before surgical resection from January 2005 to January 2015. Clinicopathological factors were evaluated to identify the independent factors predicting pathological nodal involvement by univariate and multivariate analysis. The survivals were calculated by the Kaplan-Meier method and differences in variables were analyzed by the Log-rank test in univariate analysis and the Cox proportional hazards model in multivariate analysis. RESULTS: Of the 255 cN0 NSCLC patients, 217 (85.1%) had pathological N0 status and 38 (14.9%) had pathological lymph node metastasis. Univariate analyses found a significant association between occult nodal involvement and tumor size (p = 0.021), SUVmax of the primary tumor (p < 0.001), lymphovascular invasion (LVI) (p < 0.001), visceral pleural invasion (VPI) (p < 0.001), and number of removed nodes (p = 0.001); Multivariate analysis demonstrated the LVI (P< 0.001), VPI (P = 0.009), and maximum standardized uptake value (SUVmax) (P = 0.003) were significant predictors of occult nodal involvement. Patients with higher SUVmax had significantly worse overall survival than those with lower SUVmax in univariate analysis. SUVmax and LVI was found to be independent prognostic factors according to multivariate analysis (P=0.036 and P=0.033, respectively). CONCLUSIONS: The SUVmax of primary tumor was independent predictor of occult nodal involvement and survival after surgery for cN0 NSCLC. Therefore, it can contribute to accuracy staging, risk stratification, and selecting the optimal therapeutic strategy. CLINICAL IMPLICATIONS: This promising noninvasive biomarker regarding tumor aggressive behavior could be available before surgery and enable us to identify patients at high risk of potential nodal involvement. Patients with high SUVmax should be considered for accuracy staging and intensive treatment in order to improve survival outcomes. DISCLOSURE: The following authors have nothing to disclose: Guangliang Qiang, Rui Xu, Qiduo Yu, Fei Xiao, Zhiyi Song, Yanchu Tian, Bin Shi, Chaoyang Liang, Yongqing Guo, Deruo Liu No Product/Research Disclosure Information

Preoperative prognostic prediction for invasive pulmonary adenocarcinoma: Impact of 18 F-FDG PET/CT semi-quantitative parameters associated with new histological subtype classification

Relationship between 18F-FDG PET/CT Semi-Quantitative Parameters and International Association for the Study of Lung Cancer, American Thoracic Society/European Respiratory Society Classification in Lung Adenocarcinomas

Correlation Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Pathological Subtypes of Invasive Lung Adenocarcinoma and Prognosis.

Radiomic and Quantitative-Semantic Models of Low-Dose Computed Tomography for Predicting the Poorly Differentiated Invasive Non-Mucinous Pulmonary Adenocarcinoma.

[The Prognostic Impact of Preoperative PET-CT on Postoperative Recurrence for Completely Resected Stage I Non-Small Cell Lung Cancer].

Preoperative 18F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinoma

18F-FDG PET/CT characteristics of IASLC grade 3 invasive adenocarcinoma and the value of 18F-FDG PET/CT for preoperative prediction: a new prognostication model

Role of PET/CT in Management of Early Lung Adenocarcinoma

The Potential of Basal F-18-FDG PET/CT in Evaluating Prognosis and Benefit from Adjuvant Chemotherapy after Tumor Resection of Stage IB(T2, ≤3cm with VPI, N0, M0)NSCLC

Quantitative FDG PET/CT may help risk-stratify early-stage non-small cell lung cancer patients at risk for recurrence following anatomic resection

Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma

Risk stratification in patients with advanced‐stage breast cancer by pretreatment [18F]FDG PET/CT

Predictive Value of Preoperative Pet/Ct in Resectable Clinical N0 Non-Small Cell Lung Cancer

Utility of 18F-FDG Uptake in Predicting Major Pathological Response to Neoadjuvant Immunotherapy in Patients with Resectable Non‑small Cell Lung Cancer.

SUVmax of 18FDG PET/CT Predicts Histological Grade of Lung Adenocarcinoma

[Values of Different Evaluation Criteria of Interim 18F-FDG PET/CT Scan for Prediction of Prognosis in Patients with DLBCL].

[Semiquantitative Parameters of 18F-FDG PET/CT, Gene Mutation States of Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase in Prognosis Evaluation of Patients with Lung Adenocarcinoma].

Utility of 18 F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‐small cell lung cancer

The potential of 18F-FDG PET/CT in predicting PDL1 expression status in pulmonary lesions of untreated stage IIIB-IV non-small-cell lung cancer

Preoperative Prognostic Prediction for Stage I Lung Adenocarcinomas: Impact of the Computed Tomography Features Associated with the New Histological Grading System

A nomogram based on CT intratumoral and peritumoral radiomics features preoperatively predicts poorly differentiated invasive pulmonary adenocarcinoma manifesting as subsolid or solid lesions: a double-center study